September 30, 2006 |
German drug maker Bayer mistakenly failed to inform U.S. regulators about a study on the risks of widely used heart surgery drug Trasylol before an advisory panel met and ruled that the side effects were acceptable, the company said. The Food and Drug Administration said the early findings from a new review of hospital records from 67,000 patients suggested that Trasylol use might increase the chances of death, serious kidney damage, congestive heart failure and strokes.
March 25, 2006 |
Bayer's offer for drug maker Schering was embraced by its target Friday as German rival Merck abandoned its own takeover offer. Bayer's 16.3-billion-euro ($19.6-billion) bid late Thursday trumped Merck's hostile 14.9-billion-euro ($17.9-billion) offer for Schering made March 13. Bayer CEO Werner Wenning said 6,000 jobs probably would be eliminated after the acquisition, and the company did not plan to divest any Schering units.
August 28, 2003 |
Baxter International Inc., the world's largest maker of blood disease treatments, settled a lawsuit accusing Bayer Corp. and a former employee of stealing trade secrets about Baxter's products. Terms of the agreement weren't disclosed. Baxter had claimed that Gopal Dasari, a former Baxter Healthcare Corp. scientist who joined Bayer in May, had copied files on Baxter's products for hemophilia, cancer and kidney disease.
August 27, 2003 |
Baxter Healthcare Corp., a unit of the world's largest maker of blood disease treatments, is in settlement talks with Bayer Corp. to resolve an industrial espionage case. Attorneys for the companies told U.S. District Judge William Alsup in San Francisco that they were close to settling Baxter's suit, which alleges that Gopal Dasari, a former Baxter scientist who joined Bayer in May, copied files on Baxter's leading products for hemophilia, cancer and kidney disease.
May 22, 2003 |
A U.S. judge ruled that the 1997 agreement between Barr Laboratories Inc. and Bayer to end a patent suit over the anthrax treatment Cipro wasn't anti-competitive, according to Barr. U.S. District Judge David G. Trager in Brooklyn, N.Y., rejected arguments that the settlement violated antitrust laws. The ruling narrows the scope of some 38 antitrust lawsuits filed by consumers and wholesalers against Pomona, N.Y.-based Barr and Leverkusen, Germany-based Bayer.
October 26, 2001 |
Bayer has conspired to fix the price of anti-anthrax drug Cipro and acted to delay the production of generic versions, consumer advocacy groups claim in a lawsuit. Joining a suit filed last year in New York, the groups claim that Bayer and Barr Laboratories Inc. manipulated the prices of Cipro, which has been prescribed after a series of anthrax infections in New York, Washington, New Jersey and Florida that has claimed three lives. The original suit by Louisiana Wholesale Drug Co.